Pharmacovigilance of antiretroviral dolutegravir in the state of Paraná
The aim of this study was to investigate adverse reactions to Dolutegravir, a drug recently made available by the Unified Health System (SUS) for treating HIV infections. The frequency, severity and sex distribution of adverse reactions to Dolutegravir were identified over the first 18 months of its...
Збережено в:
Автори: | , , , , |
---|---|
Формат: | Книга |
Опубліковано: |
Universidade Estadual de Maringá,
2022-01-01T00:00:00Z.
|
Предмети: | |
Онлайн доступ: | Connect to this object online. |
Теги: |
Додати тег
Немає тегів, Будьте першим, хто поставить тег для цього запису!
|
Будьте першим, хто залишить коментар!